Network Bio
Network’s AI platform built to learn human biology.
CORE INFO
Network Bio is a biotechnology company that develops AI models to advance precision medicine by integrating patient-derived biological data. Their technology aids healthcare institutions in accelerating disease detection and creating personalized therapies.
- Network Bio secured $50 million in Series A financing, led by Section 32, with participation from Thiel Bio, Founders Fund, and others.finance.yahoo.com
- The company has a strategic collaboration valued at over $30 million with a Fortune 100 healthcare company to develop next-generation AI models.finance.yahoo.com
- BioXconomy reported on Network Bio's collaboration with NVIDIA to enhance AI capabilities, highlighting their innovative approach in the field.bioxconomy.com
WHY WE WOULD WORK AT NETWORK BIO
Impactful Mission
Join a team dedicated to advancing precision medicine through innovative AI models that directly benefit patients and healthcare institutions.
Cutting-Edge Technology
Work with a bio-native AI architecture that integrates multimodal datasets, enhancing disease detection and personalized therapy development.
Collaborative Culture
Be part of a dynamic team that collaborates with industry leaders like NVIDIA, fostering a culture of innovation and shared success.
Strong Funding Support
Benefit from robust financial backing with $50 million in Series A funding, ensuring resources for ambitious projects and growth.
Notable Partnerships
Engage in high-impact projects, including a $30 million collaboration with a Fortune 100 healthcare company to develop next-generation AI models.
Professional Growth Opportunities
Leverage your skills in a fast-paced startup environment that values continuous learning and development in the rapidly evolving biotech field.
MARKET AND TRACTION
TOTAL ADDRESSABLE MARKET
NOTABLE CUSTOMERS
KEY METRICS
✦ KEY METRICGROWTH TACTICS
COMPETITIVE ADVANTAGE
PRODUCT AND TECH
Bio-Native AI Architecture
Network Bio utilizes a bio-native AI architecture designed to learn from human biological data, enabling the generation of multimodal interpretations of health across various diseases and molecular modalities.
Multimodal Datasets
The company integrates data from patient-derived tissues, blood samples, and longitudinal clinical outcomes to create multimodal datasets, which are essential for training AI models that accelerate disease detection and biomarker discovery.
AI Models for Precision Medicine
Network Bio develops disease-specific AI models that leverage comprehensive biological data to facilitate the development of personalized therapies, significantly advancing the field of precision medicine.
Collaboration with NVIDIA
By partnering with NVIDIA, Network Bio enhances its AI capabilities through the development of foundation models trained on cell-free RNA sequences, utilizing advanced computing platforms to drive innovation in medical intelligence.
Strategic Healthcare Partnerships
The company has established significant collaborations, including a $30 million agreement with a Fortune 100 healthcare company, to co-develop next-generation AI models that improve patient outcomes and healthcare efficiency.